BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38433614)

  • 1. Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19.
    Sadique MA; Yadav S; Khan R; Srivastava AK
    Chem Soc Rev; 2024 Apr; 53(8):3774-3828. PubMed ID: 38433614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
    Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
    Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
    Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
    Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
    Palaz F; Kalkan AK; Tozluyurt A; Ozsoz M
    Clin Biochem; 2021 Mar; 89():1-13. PubMed ID: 33428900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Molecular Diagnostics for COVID-19.
    Islam KU; Iqbal J
    Front Cell Infect Microbiol; 2020; 10():560616. PubMed ID: 33244462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Biosensing Platforms for Confirmation of SARS-CoV-2 Infection.
    Phan LMT; Tieu MV; Pham TT; Cho S
    Biosensors (Basel); 2021 May; 11(6):. PubMed ID: 34073756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosensors as a future diagnostic approach for COVID-19.
    Abid SA; Ahmed Muneer A; Al-Kadmy IMS; Sattar AA; Beshbishy AM; Batiha GE; Hetta HF
    Life Sci; 2021 May; 273():119117. PubMed ID: 33508293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2.
    Mahshid SS; Flynn SE; Mahshid S
    Biosens Bioelectron; 2021 Mar; 176():112905. PubMed ID: 33358285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the role of nanostructured materials in the point-of-care diagnostics for COVID-19: a comprehensive review.
    Krishnan S; Dusane A; Morajkar R; Venkat A; Vernekar AA
    J Mater Chem B; 2021 Aug; 9(30):5967-5981. PubMed ID: 34254626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2.
    Dhar A; Gupta SL; Saini P; Sinha K; Khandelwal A; Tyagi R; Singh A; Sharma P; Jaiswal RK
    Immunol Res; 2024 Feb; 72(1):14-33. PubMed ID: 37682455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemical and Bioelectrochemical Sensing Platforms for Diagnostics of COVID-19.
    Ferreira MDP; Yamada-Ogatta SF; Teixeira Tarley CR
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence.
    Flores-Contreras EA; González-González RB; Rodríguez-Sánchez IP; Yee-de León JF; Iqbal HMN; González-González E
    Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing testing regimes for the detection of COVID-19 in children and older adults.
    Chauhan N; Soni S; Jain U
    Expert Rev Mol Diagn; 2021 Oct; 21(10):999-1016. PubMed ID: 34324823
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects of nanomaterials-enabled biosensors for COVID-19 detection.
    Srivastava M; Srivastava N; Mishra PK; Malhotra BD
    Sci Total Environ; 2021 Feb; 754():142363. PubMed ID: 33254928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Technologies for Detection of COVID-19: Biosensors, Artificial Intelligence and Internet of Medical Things (IoMT): Review.
    Irkham I; Ibrahim AU; Nwekwo CW; Al-Turjman F; Hartati YW
    Sensors (Basel); 2022 Dec; 23(1):. PubMed ID: 36617023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Cost Biosensor Technologies for Rapid Detection of COVID-19 and Future Pandemics.
    de Araujo WR; Lukas H; Torres MDT; Gao W; de la Fuente-Nunez C
    ACS Nano; 2024 Jan; 18(3):1757-1777. PubMed ID: 38189684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances of Representative Optical Biosensors for Rapid and Sensitive Diagnostics of SARS-CoV-2.
    Xu M; Li Y; Lin C; Peng Y; Zhao S; Yang X; Yang Y
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current methods for diagnosis of human coronaviruses: pros and cons.
    Benzigar MR; Bhattacharjee R; Baharfar M; Liu G
    Anal Bioanal Chem; 2021 Apr; 413(9):2311-2330. PubMed ID: 33219449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Recent Update on Advanced Molecular Diagnostic Techniques for COVID-19 Pandemic: An Overview.
    Roberts A; Chouhan RS; Shahdeo D; Shrikrishna NS; Kesarwani V; Horvat M; Gandhi S
    Front Immunol; 2021; 12():732756. PubMed ID: 34970254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.
    Rashidzadeh H; Danafar H; Rahimi H; Mozafari F; Salehiabar M; Rahmati MA; Rahamooz-Haghighi S; Mousazadeh N; Mohammadi A; Ertas YN; Ramazani A; Huseynova I; Khalilov R; Davaran S; Webster TJ; Kavetskyy T; Eftekhari A; Nosrati H; Mirsaeidi M
    Nanomedicine (Lond); 2021 Mar; 16(6):497-516. PubMed ID: 33683164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.